Tocilizumab in the treatment of coronavirus disease 2019 pneumonia: real-world data from a case series

Aim: Coronavirus disease 2019 is a life-threatening disease and how to improve survival of the patients is of great importance. Objective: To determine whether tocilizumab (TCZ) shows favorable results in coronavirus disease 2019 patients. Materials & methods: A retrospective study of four patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Ran, Zhu, Ying, Wang, Yulan, Chen, Xiao-Hua, Li, Qiang, Dai, Sheng-Ming, Tong, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151543/
https://www.ncbi.nlm.nih.gov/pubmed/34055031
http://dx.doi.org/10.2217/fvl-2020-0410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151543/
https://www.ncbi.nlm.nih.gov/pubmed/34055031
http://dx.doi.org/10.2217/fvl-2020-0410

Ejemplares similares